Humanized anti-carcinoembryonic antigen antibody: strategies to enhance human tumor cell killing.
First Department of Internal Medicine, Johannes Gutenberg University, Mainz, FRG.
H
H
Kaulen
G
G
Seemann
K
K
Bosslet
W
W
Schwaeble
W
W
Dippold
D000818:Animals; D000911:Antibodies, Monoclonal / Q000235:genetics / Q000276:immunology*; D000912:Antibodies, Neoplasm / Q000235:genetics / Q000276:immunology*; D002272:Carcinoembryonic Antigen / Q000276:immunology*; D003167:Complement Activation; D011415:Complement Factor B / Q000235:genetics / Q000276:immunology*; D004247:DNA / Q000235:genetics; D005803:Genes, Immunoglobulin; D005813:Genes, Synthetic; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000235:genetics / Q000276:immunology; D051379:Mice; D016297:Mutagenesis, Site-Directed; D015202:Protein Engineering; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000276:immunology*; D013045:Species Specificity
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D002272:Carcinoembryonic Antigen; D007140:Immunoglobulin Fab Fragments; D011993:Recombinant Fusion Proteins; D004247:DNA; D011415:Complement Factor B